Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-067022
Filing Date
2025-07-10
Accepted
2025-07-10 16:48:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2519996-1_s3.htm S-3 432338
2 EXHIBIT 4.4 tm2519996d2_ex4-4.htm EX-4.4 318387
3 EXHIBIT 5.1 tm2519996d2_ex5-1.htm EX-5.1 18488
4 EXHIBIT 23.1 tm2519996d2_ex23-1.htm EX-23.1 2259
5 EX-FILING FEES tm2519996d2_ex-filingfees.htm EX-FILING FEES 64296
6 GRAPHIC tm2519996d2_ex5-1img001.jpg GRAPHIC 3264
7 GRAPHIC lg_centurythera-4c.jpg GRAPHIC 19514
  Complete submission text file 0001104659-25-067022.txt   868495
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288616 | Film No.: 251116783
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)